Pharma Journalist -

Daiichi Sankyo announced that VANFLYTA (quizartinib) has been approved by the U.S. Food and Drug Administration (FDA) in combination with standard cytarabine and anthracycline induction…
Read More...

Ipsen announced that the European Commission has followed guidance provided by the Committee for Medicinal Products for Human Use (CHMP) in May this year, and has not granted marketing…
Read More...

BioCryst Pharmaceuticals, Inc. announced the company has entered into a collaboration with Er-Kim Pharmaceuticals to commercialize ORLADEYO (berotralstat) in Turkey. “We continue our…
Read More...

Eleven Therapeutics, a biotechnology company developing next-generation RNA therapeutics through the mastery of combinatorial chemistry and artificial intelligence, announced a research…
Read More...

Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application (sNDA) for the use of Veklury (remdesivir) in COVID-19…
Read More...

Given the resurgence of investment and investigation into oligonucleotides, the Oligonucleotide CMC & Analytical Development team did an exclusive interview with leading industry…
Read More...

Astellas Pharma Inc. announced the European Medicines Agency (EMA) has accepted for regulatory review the company's marketing authorization application (MAA) for zolbetuximab, a…
Read More...

Gilead Sciences, Inc. is pleased to announce two public-private partnerships. The first will accelerate the development of an investigational dispersible pediatric formulation…
Read More...

The oligonucleotide field is ever evolving at a rapid pace, as experts continue to optimize manufacturing processes, develop robust analytical methods, and ensure the quality and safety…
Read More...

InnoCare Pharma and ArriVent Biopharma announced a clinical development collaboration to evaluate the combination of InnoCare’s novel SHP2 (Src Homology 2 domain containing protein…
Read More...